Semaglutide, the active ingredient in Novo Nordisks blockbuster diabetes and weight-loss medications Ozempic and Wegovy, has been on the FDAs shortage list since March 2022
Heres what research tells us so far: Studies including over 1,000 women exposed to GLP-1s during the first trimester have not shown an increased chance of birth defects
Within that band, the exact dosage schedule is established one member at a time: our physician-prescribed protocol, aided by Nooms SmartDose experience, guides members to the lowest dose that achieves health goals
When patients understand that mild nausea often improves over time, they are more likely to continue therapy through the titration phase
Klarity providers evaluate patients for GLP-1 eligibility, write prescriptions for clinically appropriate candidates, and provide ongoing medication management, all online
This type of intense change can be hard to sustain in the long term